Department of Neurooncology, Fondazione IRCCS Istituto Neurologico C. Besta, Via Celoria, 11, 20133, Milan, Italy.
Support Care Cancer. 2012 Jun;20(6):1327-32. doi: 10.1007/s00520-011-1220-y. Epub 2011 Jul 3.
Despite advances in therapies that offer improved survival rates, clinical course of brain tumours leads to a progressive functional deterioration in patients with modifications in their psychological reaction to the disease. Patients with brain tumours are rarely assessed for quality of life and psychological variables, and even fewer studies have assessed patients who have experienced a recurrence of brain tumours. Therefore, the aim of the present study is to investigate the patients with recurrent brain tumours and their reaction to the illness.
We enrolled 81 patients with recurrent CNS tumours. Karnofsky Performance Status scale (KPS) was used to evaluate functional status of patients; the multidimensional aspect of quality of life was assessed through "Functional Assessment of Cancer Therapy-Brain" (FACT-Br), "Hospital Anxiety and Depression Scale" and "Psychological Distress Inventory". These were all used as tests of psychological well-being.
Distress and almost all mean FACT-Br subscale scores seemed to be significantly lower in patients, in comparison with normative data. Surprisingly, the emotional well-being mean score was significantly higher in our recurrence sample than in patients with brain tumours at first diagnosis. Anxiety seemed not to be influenced by a relapse diagnosis; instead, depression was higher and differed significantly from normative data. Low correlation between KPS and FACT-Br total and some sub-scores was found.
Apparent dissociation between patients' judgment on their quality of life (bad except for emotional) and their reported distress (low) is the most intriguing finding, suggesting highly preserved coping strategies in the emotional sphere, despite intact judgment and disease awareness.
尽管治疗方法的进步提高了生存率,但脑瘤的临床病程导致患者的功能逐渐恶化,他们对疾病的心理反应也发生了变化。脑瘤患者很少接受生活质量和心理变量的评估,更少的研究评估过经历脑瘤复发的患者。因此,本研究旨在调查复发性脑瘤患者及其对疾病的反应。
我们招募了 81 名复发性中枢神经系统肿瘤患者。卡氏功能状态量表(KPS)用于评估患者的功能状态;通过“癌症治疗脑功能评估量表-FACT-Br”(FACT-Br)、“医院焦虑和抑郁量表”和“心理困扰量表”评估多维生活质量。这些都被用作心理健康测试。
与常模数据相比,困扰和几乎所有 FACT-Br 子量表的平均得分似乎明显较低。令人惊讶的是,我们的复发性样本的情绪健康平均得分明显高于首次诊断为脑瘤的患者。焦虑似乎不受复发诊断的影响;相反,抑郁得分较高,与常模数据有显著差异。还发现 KPS 与 FACT-Br 总分和一些子量表之间的相关性较低。
患者对生活质量的判断(除了情绪外都很差)和他们报告的困扰(低)之间明显的脱节是最有趣的发现,这表明在情感领域保持了高度的应对策略,尽管对疾病的认识和判断力保持完好。